HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Quinolone use in the developing world: state of the art.

Abstract
The development of bacterial resistance to previously recommended standard therapy for common childhood infections in developing countries, notably dysentery and invasive salmonellosis, has left treatment options limited to the quinolones. A number of randomised controlled trials of the quinolones in shigellosis have demonstrated their efficacy and safety in children. Strategies to make these drugs available in developing countries for specific indications should be devised. Quinolones, however, should be limited to specific indications in order to prevent the emergence of bacterial resistance and thus preserve their clinical efficacy for important childhood infectious diseases in developing countries.
AuthorsT E Tupasi
JournalDrugs (Drugs) Vol. 58 Suppl 2 Pg. 55-9 ( 1999) ISSN: 0012-6667 [Print] New Zealand
PMID10553707 (Publication Type: Journal Article, Review)
Chemical References
  • Anti-Infective Agents
  • Fluoroquinolones
Topics
  • Anti-Infective Agents (therapeutic use)
  • Child
  • Developing Countries
  • Diarrhea (drug therapy)
  • Drug Resistance, Microbial
  • Drug Utilization
  • Dysentery, Bacillary (drug therapy)
  • Fluoroquinolones
  • Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: